Virmo

Liselotte Højgaard

Direktørposter 0 Se alle › Bestyrelsesposter 3 Se alle › Selskaber 70 Se alle ›

Oversigt

Om Liselotte Højgaard

Liselotte Højgaard startede sin erhvervskarriere i ARVID NILSSONS FOND tilbage i 2010. I dag er Liselotte aktiv i 73 virksomheder.

Ud fra vores kendskab har Liselotte 218 netværksforbindelser gennem sit ejerskab af virksomheder, bestyrelsesposter m.m.

Karriere start

ARVID NILSSONS FOND › Bestyrelsesmedlem

Største overskud

126.171.000’ DKK NOVO NORDISK FONDEN › 2024

Laveste overskud

-3.363.817’ DKK XELLIA GROUP ApS › 2023

Største egenkapital

411.227.000’ DKK NOVO NORDISK FONDEN › 2024

Største gæld

262.510.000’ DKK NOVO NORDISK FONDEN › 2024

Direktørposter

Der er ingen direktørposter registreret

Forbindelser

Sisse Fjelsted Rasmussen

Via:

Andreas Nahne Nickelsen

Via DADES A/S ›

Søren René Kristiansen

Via:

Karsten Holst Bork Kristoffersen

Via:

Jacob Lise Lyngsgaard

Via:

Christopher Ashby Voigt

Via:

Ole Jakob Müller

Via:

Andreas Hvid Risvang Clement

Via:

Nana Sejbæk

Via:

Lars Henrik Fugger

Via:

Stig Strøbæk

Via:

Mads Boritz Grøn

Via:

Lars Rebien Sørensen

Via:

Lars Henrik Munch

Via:

Marianne Willumsen

Via DADES A/S ›

Steen Riisgaard

Via:

Jess Jehl

Via ARVID NILSSONS FOND ›

Kåre Bo Stolt

Via ARVID NILSSONS FOND ›

Niels Henrik Roth

Via ARVID NILSSONS FOND ›

Christian Schow Madsen

Via ARVID NILSSONS FOND ›

Erik Preben Holm

Via ARVID NILSSONS FOND ›

Matias Møl Dalsgaard

Via:

Anne Andersen

Via:

Stina Vrang Elias

Via:

Kristian May

Via:

Rina Asmussen

Via:

Christian Salling

Via:

Andreas Morthorst

Via ELLAB A/S ›

Gergely Svéd

Via ELLAB A/S ›

Anders Hedegaard

Via ELLAB A/S ›

Henrik Kjær Hansen

Via:

Morten Egholm Aagaard

Via ELLAB A/S ›

Michael Kjær

Via ELLAB A/S ›

Lars Erik Holmqvist

Via ELLAB A/S ›

Henrik Sindal Jensen

Via ELLAB A/S ›

Susanne Krüger Kjær

Via ELLAB A/S ›

Katja Barnkob

Via ELLAB A/S ›

Steffen Kragh

Via ELLAB A/S ›

Søren Skou

Via ELLAB A/S ›

Svend Andersen

Via ELLAB A/S ›

Mikkel Helmer Nielsen

Via ELLAB A/S ›

Thomas Mears Werge

Via ELLAB A/S ›

Karen Holdaway Grøn

Via TAGEA BRANDTS REJSELEGAT ›

Lasse Horne Kjældgaard

Via TAGEA BRANDTS REJSELEGAT ›

Christian Johannes Gellert Nielsen

Via:

Morten Peltola Toft

Via:

Kim Vorbeck Jans

Via SONION A/S ›

Michael Peter Willumsen

Via:

Niels-Peter Edvardsen

Via:

Henriette Berg-Deleuran

Via:

Søren Skov

Via:

Torsten Hoffmeyer

Via:

C.L. DAVIDS FOND OG SAMLING

Via DAVISTA KOMPLEMENTARSELSKAB A/S ›

Marie-Louise Bech Nosch

Via:

Henrik Wivel

Via DAVISTA KOMPLEMENTARSELSKAB A/S ›

Poul Erik Tøjner

Via DAVISTA KOMPLEMENTARSELSKAB A/S ›

Cristina Patricia Lage

Via DAVISTA KOMPLEMENTARSELSKAB A/S ›

Søren Hostrup

Via:

Michael Kocher

Via:

Eva Blem

Via:

Xellia Group AS

Via XELLIA GROUP ApS ›

Vagn Leo Jacobsen

Via SOEBORG EJENDOMME ApS ›

Nik Economopoulos

Via ACESION PHARMA ApS ›

Timothy Michael Shannon

Via ACESION PHARMA ApS ›

Benjamin Bruno Thorner

Via ACESION PHARMA ApS ›

Anders Gaarsdal Holst

Via ACESION PHARMA ApS ›

Jørgen Søberg Petersen

Via:

Ulrik Svane Sørensen

Via ACESION PHARMA ApS ›

Morten Grunnet

Via ACESION PHARMA ApS ›

Canaan XII L.P.

Via ACESION PHARMA ApS ›

Alpha Wave Ventures II, LP

Via ACESION PHARMA ApS ›

FC Inbio Holdings Limited

Via ACESION PHARMA ApS ›

Søren Justesen

Via XELLIA HOLDCO A/S ›

Claus Hansen

Via:

Thomas Grotkjær

Via:

Joško Bobanović

Via BIOSYNTIA ApS ›

Sara Sande

Via BIOSYNTIA ApS ›

Michael Jean Nettersheim

Via BIOSYNTIA ApS ›

Martin Plambech

Via BIOSYNTIA ApS ›

Henrik Dalbøge

Via BIOSYNTIA ApS ›

Praesidium S.C.A. SICAV-RAIF

Via BIOSYNTIA ApS ›

ECBF I SCSp

Via BIOSYNTIA ApS ›

Sofinnova Industrial Biotech I

Via BIOSYNTIA ApS ›

Benny Dalgaard Loft

Via NEW XELLIA GROUP A/S ›

Julie McHugh

Via NEW XELLIA GROUP A/S ›

Preben Haaning

Via NEW XELLIA GROUP A/S ›

Barbara Fiorini

Via SONION HOLDCO A/S ›

Axel Tobias Vieth

Via Fisketorvet 2 Odense ApS ›

Camilla Petrycer Hansen

Via Hoba Therapeutics ApS ›

Gonçalo Nuno Nunes da Silva Rebelo de Andrade

Via Hoba Therapeutics ApS ›

Gunnar Magnus Severus Modée Persson

Via Hoba Therapeutics ApS ›

Kuang He

Via Hoba Therapeutics ApS ›

Torsten Meldgaard Madsen

Via Hoba Therapeutics ApS ›

Jean Marcel André Combalbert

Via Hoba Therapeutics ApS ›

Indaco Venture Partners SGR S.p.A.

Via Hoba Therapeutics ApS ›

MIJ Biotech-Global Limited Partnership

Via Hoba Therapeutics ApS ›

Eir Ventures I AB

Via Hoba Therapeutics ApS ›

EIC Fund

Via Hoba Therapeutics ApS ›

Philip Just Larsen

Via Antag Therapeutics ApS ›

Mark Currie

Via Antag Therapeutics ApS ›

Alexander Volker Wilhelm Mayweg

Via Antag Therapeutics ApS ›

Amit Kantilal Shah

Via Antag Therapeutics ApS ›

Jörg Möller

Via Antag Therapeutics ApS ›

Mette Marie Rosenkilde

Via Antag Therapeutics ApS ›

Maria Buur Nordskov Gabe

Via Antag Therapeutics ApS ›

Jens Juul Holst

Via Antag Therapeutics ApS ›

Dawn Holdco SCSp

Via Antag Therapeutics ApS ›

Versant Venture Capital VII, L.P.

Via Antag Therapeutics ApS ›

SR One Capital Fund II Aggregator, LP

Via Antag Therapeutics ApS ›

Broadview Ventures I LLC

Via Antag Therapeutics ApS ›

João Carlos Ribas de Almeida

Via BiOrigin ApS ›

Søren Sylvester Skjærbæk

Via:

Emmanuelle Coutanceau

Via:

Mads Aage Laustsen

Via Bactolife A/S ›

Morten Aleksandr Engel

Via Bactolife A/S ›

Frank Julian Zachmann

Via Bactolife A/S ›

Rhonda Doyce Hoffman

Via Bactolife A/S ›

Claus Sebastian Søderberg

Via Bactolife A/S ›

Jørgen Rugholm Jensen

Via Bactolife A/S ›

ATHOS Biopharma GmbH

Via Bactolife A/S ›

Bill & Melinda Gates Foundation

Via Bactolife A/S ›

Claus Steensen Sølje

Via Sonion Holding A/S ›

Mikael Worning

Via Sonion Holding A/S ›

Verena Vescoli

Via Sonion Holding A/S ›

Louise Marie Janssen-Counotte

Via Sonion Holding A/S ›

Petrus Antonius Johannes Coelewij

Via Sonion Holding A/S ›

Wellington Partners V Life Sciences Fund

Via STIPE Therapeutics ApS ›

Ulrik Mouritzen

Via Breye Therapeutics ApS ›

Chiara Rossana Maria Liberati

Via Breye Therapeutics ApS ›

Carl Johan Kördel

Via Breye Therapeutics ApS ›

Gabriela Burian

Via Breye Therapeutics ApS ›

Jimmy Arnold V Van Heusden

Via Breye Therapeutics ApS ›

Golgi NueroSciences S.R.L.

Via Breye Therapeutics ApS ›

Sound Bioventures Fund I AB

Via Breye Therapeutics ApS ›

Mogens Ebeling

Via:

Mads Jensen

Via BRFinvest a/s ›

Allan Soon Lorentzen

Via BRFinvest a/s ›

Claus Crone Fuglsang

Via 21st.BIO A/S ›

Thomas Günther Schmidt

Via 21st.BIO A/S ›

Thomas Dal Stenfeldt Batchelor

Via 21st.BIO A/S ›

Jose Arnau Martinez

Via 21st.BIO A/S ›

Mikael Bechsgaard

Via 21st.BIO A/S ›

Thomas Troelsgaard Kabel

Via 21st.BIO A/S ›

Henrik Marcus Geertz-Hansen

Via 21st.BIO A/S ›

Anders Bendsen Spohr

Via 21st.BIO A/S ›

Lars Bjørn Houlind

Via:

Lars Bo Køppler

Via:

Anne Marie Handrup Kverneland

Via:

Marianne Philip

Via:

Morten Beck Jørgensen

Via Renewable Energy Partnership P/S ›

Jens-Peter Zink

Via:

Torbjørn Lange

Via Renewable Energy Partnership P/S ›

Rasmus Tore Lund Jacobsen

Via Renewable Energy Partnership P/S ›

Knud Erik Andersen

Via:

JPZ Sweden AB

Via Renewable Energy Partnership I CIV K/S ›

Jørgen Buhl Rasmussen

Via Matr Foods ApS ›

Thomas Bjerregaard Thomsen

Via Matr Foods ApS ›

Randi Riisager Wahlsten

Via Matr Foods ApS ›

Claus Meyer Nielsen

Via Matr Foods ApS ›

Line Kloster Pedersen

Via Matr Foods ApS ›

Leoni Johanna Jahn

Via Matr Foods ApS ›

Cristina Megias Torrego

Via Matr Foods ApS ›

Claus Schei Mathisen

Via Baneby Konsortiet GP ApS ›

Søren Tang Kristensen

Via Baneby Konsortiet GP ApS ›

NREP NSF IV Holding 2 S.à. r.l

Via Baneby Konsortiet GP ApS ›

NREP NSF V Holding 2 S.à. r.l.

Via:

Pieter Jeroen Bakker

Via Commit Biologics ApS ›

Nick Stub Laursen

Via Commit Biologics ApS ›

Roderick Verhelst

Via Commit Biologics ApS ›

Janine Schuurman

Via Commit Biologics ApS ›

Eva Van Overmeire

Via Commit Biologics ApS ›

Mikkel Wandahl Pedersen

Via Commit Biologics ApS ›

Anker Gunvald Lundemose

Via Commit Biologics ApS ›

Korys Investments

Via Commit Biologics ApS ›

Bioqube Factory Fund I CommV

Via Commit Biologics ApS ›

Søren Møller

Via Orbis Medicines ApS ›

Morten Døssing

Via Orbis Medicines ApS ›

Marco Boorsma

Via Orbis Medicines ApS ›

Alonso Ricardo Rodriguez

Via Orbis Medicines ApS ›

Edward Timothy Mathers

Via Orbis Medicines ApS ›

Goran Mikael Dolsten

Via Orbis Medicines ApS ›

GF 2022 Global VC S.á r.l.

Via Orbis Medicines ApS ›

Forbion Ventures Fund VI Coöperatief U.A.

Via Orbis Medicines ApS ›

Lily Low Parshall Wachter

Via Biomason Denmark ApS ›

Camilo Restrepo Restrepo

Via Biomason Denmark ApS ›

bioMASON Inc.

Via Biomason Denmark ApS ›

Mark Charles Houston

Via Biomason Denmark ApS ›

Diarmuid Phelan

Via Biomason Denmark ApS ›

Claes Johan Gustaf Geijer

Via Biomason Denmark ApS ›

Pelle Kristoffer Munk-Poulsen

Via:

Søren Nedergaard

Via:

Mads Krogsgaard Thomsen

Via:

Jan Westenkær Thomsen

Via Quantum Foundry P/S ›

Celia Irene Merzbacher

Via Quantum Foundry P/S ›

Peter Krogstrup Jeppesen

Via Quantum Foundry P/S ›

Lene Broeng Oddershede

Via Quantum Foundry P/S ›

Marcus Ludger Remmers

Via Antraka ApS ›

Erika Johanna Söderberg Johnsson

Via:

Charlotte Bonefeld

Via NIVI Development P/S ›

Marianne Holm

Via NIVI Development P/S ›

Nicholas Aubrey Corbett Jackson

Via NIVI Development P/S ›

Peter Andersen

Via NIVI Development P/S ›

Thomas Hassing Ronøe Carlsen

Via Novo Nordisk Foundation Cellerator P/S ›

Andreas Cleve

Via Danish Centre for AI Innovation A/S ›

Peder Lundquist

Via Danish Centre for AI Innovation A/S ›

Nadia Catherine Carlsten

Via Danish Centre for AI Innovation A/S ›

Dorothy Atieno Owegi

Via NNF Kenya A/S ›

Marie Allen Schroeder

Via RefuelBio ApS ›

Marcia Haigis

Via RefuelBio ApS ›

Johannes Thon

Via Repowering Partnership DE ApS ›

Reinaldo Miguel Diaz

Via RheumaLogics ApS ›

Demetrios Thomas Braddock

Via RheumaLogics ApS ›

Henrik Tordrup

Via GF I Delos TopCo ApS ›

Lars Holme Villadsen

Via GF I Delos TopCo ApS ›

Steen Lønberg Jørgensen

Via GF I Delos TopCo ApS ›

Lars Beck Madsen

Via XELLIA PHARMACEUTICALS ApS ›

Martin Bech

Via XELLIA PHARMACEUTICALS ApS ›

Michael Uhd

Via XELLIA PHARMACEUTICALS ApS ›